“our first trial includes blind patients who are not suitable candidates for, or have failed one or more corneal transplantations,” said almog aley-raz, corneat vision’s co-founder, ceo and vice-president of research and development. “given the visual performance of our device, the expected healing time and retention and the fact that it cannot carry disease, we plan to initiate a second study later this year with broader indications to approve our artificial cornea as a first line treatment, displacing the use of donor tissue used in full thickness corneal transplantations.”
the news should come as a welcome relief to thousands of canadians, some of whom have endured painful vision loss while waiting as long as two years for a cornea transplant,
according to cbc news. corneal tissue has even gone to waste in the country due to what some experts describe as a lack of cooperation that has resulted in a system where some provinces use different health organizations than others to provide the necessary accreditation on donated tissue.
“in canada, the canadian blood system, there’s all accountability and accreditation in place so that if i get a pint of blood from calgary, i know it’s the same as i get from vancouver,” said paul dubord, a surgeon and world health organization corneal expert. “but in tissue transplantation, that doesn’t exist, so a cornea that’s collected in quebec, we might not know.”
while other countries, such as the u.s., have virtually eliminated corneal blindness largely because of a lack of waiting time, dubord said canada is still struggling to streamline its process. “there is no reason why there should be corneal blindness in canada,” he said. “we have the ability, we have all the elements in place to eliminate corneal blindness in canada, and all those elements need to be working in concert to achieve that goal.”